Oxygen administration improves the serum level of nitric oxide metabolites in patients with obstructive sleep apnea syndrome

Sleep Medicine

Volumn 4, Issue 5, 2003, Pages 403-407

  Teramoto, Shinji ^a   Kume, Haruki ^b   Matsuse, Takeshi ^c   Ishii, Takeo ^c   Miyashita, Akira ^c   Akishita, Masahiro ^d   Toba, Kenji ^d   Ouchi, Yasuyoshi ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^b INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^c YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^d KYORIN UNIVERSITY   (Japan)

Author keywords

Hypoxia; Nitric oxide; Obstructive sleep apnea syndrome; Oxygen administration

Indexed keywords

NITRATE; NITRIC OXIDE; NITRITE; OXYGEN;

ADULT; AGED; APNEA; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; HYPOTHESIS; HYPOXIA; MALE; METABOLITE; OXYGEN THERAPY; PATHOGENESIS; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SLEEP APNEA SYNDROME; STATISTICAL ANALYSIS; VASODILATATION;

EID: 0141446377     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1389-9457(03)00102-3     Document Type: Article

References (21)

1. Guilleminault C, Tilkian A, Dement WC. The sleep apnea syndromes. Annu Rev Med 1976;27:465-84.
2. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328:1230-5.
3. Teramoto S, Ohga E, Ouchi Y. Obstructive, sleep apnoea. Lancet 1999;354:1213-4.
4. Jenkinson C, Davies RJ, Mullins R, et al. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet 1999;353:2100-5.
5. Teramoto S, Matsuse T, Ouchi Y. Does the altered cardiovascular variability associated with obstructive sleep apnea contribute to development of cardiovascular disease in patients with obstructive sleep apnea syndrome? Circulation 1999;100:e136-7.
6. Teramoto S, Matsuse T, Fukuchi Y. Clinical significance of nocturnal oximeter monitoring for detection of sleep apnea syndrome in the elderly. Sleep Med 2002;3:17-21.
7. Ziegler MG, Nelesen R, Mills P, et al. Sleep apnea, norepinephrine-release rate, and daytime hypertension. Sleep 1997;20:224-31.
8. Teramoto S, Kume H, Matsuse T, et al. The risk of future cardiovascular diseases in the patients with OSAS is dependently or independently associated with obstructive sleep apnoea. Eur Respir J 2001;17:573-4.
9. Hoover DB, Chang Y, Hancock JC, et al. Actions of tachykinins; within the heart and their relevance to cardiovascular disease. Jpn J Pharmacol 2000;84:367-73.
10. Ozaki K, Yamamoto T, Ishibashi Y, et al. Regulation of endothelial nitric oxide synthase and endothelin-1 expression by fluvastatin in human vascular endothelial cells. Jpn J Pharmacol 2001;85:147-54.
11. Giaid A, Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 1995;333:214-21.
12. Stamler JS, Loh E, Roddy MA, et al. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation 1994;89:2035-40.
13. Kharitonov SA, Cailes JB, Black CM, et al. Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension. Thorax 1997;52:1051-5.
14. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, et al. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 1991;338:1173-4.
15. Teramoto S, Fukuchi Y, Orimo H. Effects of anticholinergic drug on dyspnea and gas exchange in patients with chronic obstructive pulmonary disease. Chest 1993;103:1774-82.
16. Teramoto S, Sudo E, Mstsuse T, et al. Impaired swallowing reflex in patients with obstructive sleep apnea syndrome. Chest 1999;116: 17-21.
17. Watanabe T, Akishita M, Toka M, et al. Influence of sex and age on serum nitrite/nitrate concentration in healthy subjects. Clin Chim Acta 2001;301:169-79.
18. Ip MS, Lam B , Chan LY, et al. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 2000;162:2166-71.
19. Schulz R, Schmidt D, Blum A, et al. Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnea: response to CPAP therapy. Thorax 2000;55:1046-51.
20. Carlson J, Hedner J, Pettersson A. Increased plasma concentration of ADMA, a naturally occurring nitric oxide synthesis inhibitor, in OSA patients. Am J Respir Crit Care Med 1997;155:A869.
21. Kato M, Roberts-Thomson P, Phillips BG, et al. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 2000;102:2607-10.